Discovery Company Webinar

InvestorHub Discovery Series

Discovery Webinar Series- 25 February 5:00pm

ShareSoc, in collaboration with InvestorHub, presents a webinar series designed to spotlight small and midcap companies listed on AIM or the Aquis Exchange, with the aim of providing insights into innovative and high growth prospects within the market.

In February we are pleased to feature: N4 Pharma PLC (N4P) and SEEEN plc (SEEN)

N4 Pharma PLC (N4P)

N4 Pharma is a biotech company developing Nuvec®, its proprietary gene delivery system, to enable advanced therapies for cancer and other diseases.

RNA therapeutics are set to impact the treatment of a wide range of diseases and Nuvec® has several key advantages for RNA gene delivery including the ability to deliver multiple RNA therapies in a single particle, ease manufacturing, protection of the RNA payload to allow for oral delivery, no unwanted immune response and excellent stability and storage.

N4 Pharma is building out its preclinical data set and working towards first-in-human clinical data to support significant licensing deals for its Nuvec® platform with gene therapy partners.

N4 Pharma’s lead programme, N4 101, is an oral anti-inflammatory product for inflammatory bowel disease (IBD) which serves as a proof-of-concept programme showcasing all the benefits of the Nuvec® platform. With an estimated 10 million people globally suffering from Crohn’s disease and ulcerative colitis, the IBD treatment market was worth $20.4bn in 2023 and is expected to grow by a CAGR of 3.9% to over $27.6bn by 2030, driven by both increased incidences of the disease and development of new treatments.

For further information on the Company visit www.n4pharma.com or sign up at https://investors.n4pharma.com/auth/signup.

Presenter: Nigel Theobald, CEO
Nigel has over 25 years’ experience in healthcare and in building businesses, strategy development and its implementation and a strong network covering all aspects of pharmaceutical product development and commercialisation. He was the head of healthcare brands at Boots Group plc in 2002 before leaving to set up a series of successful businesses, including Oxford Pharmascience Group plc, which he grew over 5 years into an AIM quoted company with a market capitalisation of £40 million upon departure. Nigel formed N4 Pharma in 2014.

SEEEN plc (SEEN)

SEEEN is a video technology company that uses AI to identify, create and monetise interactive Key Video Moments within large scale video collections. Its technology is used by clients to drive greater revenues from video commerce, accessible training and increased social video footprints all from their existing back catalogue of content.

Presenter: Adrian Hargrave, CEO
Adrian is CEO of SEEEN plc, having been with the company since its IPO in 2019, initially as CFO and subsequently as CEO, where he has been responsible for transforming the group’s go to market strategy for the group’s technology offering, leading to consistent year on year increases in technology sales. Adrian’s previous experience includes working as Corporate Development Director at Water Intelligence plc, as well as at City-facing firms Cenkos Securities and finnCap

Registration

If you are already a member of ShareSoc you must log in prior to registering, then just click “REGISTER” below. If you are not already a member of ShareSoc, please complete the form below to sign up as an Associate (free) member and then click “REGISTER”.

Click here for help on logging in.

Once you have registered you will receive an email notification, as well as reminders 1 day and 1 hour before the event starts.

Register for Webinar

Add to calendar
Event Details:
  • Event: Discovery Company Webinar
  • Date: 25/02/2025
  • Time: Presentations Start at 5pm
  • Location: Webinar
Add to calendar
Event Details:
  • Event Discovery Company Webinar
  • Date 25/02/2025
  • Time Presentations Start at 5pm
  • Location Webinar
  • Description Companies presenting:
    N4 Pharma PLC (N4P)
    SEEEN plc (SEEN)